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ABSTRACT
Objectives: Research suggests that girls from ethnic
minority groups are less likely to receive the human
papillomavirus (HPV) vaccination than white British
girls; however, the specific ethnic minority groups
that have lower uptake have not been identified. This
study aimed to examine the relationship between
school-level uptake and ethnicity as well as uptake
and other ethnicity-related factors, to understand
which specific groups are less likely to receive the
vaccination.
Methods: Aggregated uptake rates from 195 schools
were obtained for each of the three recommended
vaccine doses from 2008 to 2010. Census data at the
lower super output area (LSOA) level for the
postcode of each school were also obtained,
describing the ethnic breakdown of the resident
population (ethnicity, language spoken, religion,
proficiency in English and duration of residency in
the UK). These were used as proxy measures of the
ethnic make-up of the schools. The most prevalent
non-majority group for each ethnicity and ethnicity-
related factor was assigned to each school. Analyses
explored differences in uptake by ethnicity and
ethnicity-related factors.
Results: No significant differences in vaccination
uptake were found by ethnicity or ethnicity-related
factors, although descriptive differences were
apparent. Schools in areas where black ethnicities
were the most prevalent non-white British
ethnicities had consistently low rates of uptake for
all doses. Schools in areas where some Asian
ethnicities were the most prevalent non-white British
ethnicities had consistently high rates of uptake for
all doses. There was evidence of variability in mean
uptake rates for ethnicities within ‘black’ and ‘Asian’
ethnic groups.
Conclusions: Future research would benefit from
focusing on specific ethnicities rather than broad
ethnic categories. Replication of this study with a
larger sample and using complete individual-level
data, collected on a national level, would provide a
clearer indication of where ethnic differences in HPV
vaccination uptake exist.
INTRODUCTION
Human papillomavirus (HPV) is a common
DNA virus that affects the skin and moist
membranes that line parts of the body, such
as the cervix. It is passed on through
skin-to-skin contact and can be sexually trans-
mitted. HPV infection is very common in
sexually active individuals and there is a strong
relationship between the number of lifetime
and recent new sexual partner(s) and HPV
infection.1 The majority of HPV infections are
asymptomatic and transient; however, persist-
ent infection with high-risk types of HPV is
the primary cause of cervical cancer.2
A vaccination against HPV is available as
part of the UK childhood immunisation
schedule. The vaccination is offered free of
charge, delivered mainly through schools and
is recommended for all girls aged 12–13 years
old. The vaccine is currently administered in
a two-dose schedule, however, three doses
were required prior to September 2014.3
Since the introduction of the vaccination,
high coverage has been achieved in England
with recent government ﬁgures reporting
that 89.4% of girls received at least one dose
Strengths and limitations of this study
▪ By examining the relationship between uptake of
the human papillomavirus vaccination and ethni-
city, and other factors related to ethnicity, we
were able to identify ethnic groups for whom
uptake of the vaccination was consistently low.
▪ We were able to demonstrate variability in mean
uptake rates between ethnicities that would
otherwise be grouped into broad ethnic catego-
ries, thus losing such detail.
▪ Further exploration is recommended with a larger
sample size, using individual-level ethnicity and
uptake data.
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in 2014/2015.4 However, research has shown that there
are disparities in uptake between girls from white British
backgrounds and ethnic minority backgrounds. Pilot
implementation of the vaccination, carried out prior to
national roll-out, concluded that although delivery was
possible, non-white girls were less likely to be vaccinated
than white girls5 and that uptake was signiﬁcantly lower
in schools with higher proportions of girls from ethnic
minority groups.6 Comparable results have been
reported following the introduction of the vaccination;
Fisher et al7 examined routine vaccination data for
14 282 young women eligible for the HPV vaccination
and found that girls from non-white British backgrounds
(mixed ethnicity, Asian, black and ‘Chinese and other’)
were less likely to initiate the vaccination compared with
white British girls. Similar ﬁndings were also reported in
a review of the literature which found that young black
women were less likely to initiate the vaccination than
young white women.8 It is important to note that not all
studies in this review were UK based, which suggests that
this is a global issue and not just UK speciﬁc.
When discussing ethnicity, it is important to consider
other factors that might confound the relationship
between ethnicity and health. Deprivation and ethnicity
are often related9 and deprivation has been shown to
predict uptake of the vaccination.5 However, the relation-
ship between ethnicity and uptake of the HPV vaccination
has been shown to be signiﬁcant irrespective of depriv-
ation7 and it has not been found to explain ethnic differ-
ences in acceptability10 or in uptake of the vaccination.5
Although differences in uptake rates between white
British and ethnic minority groups have been estab-
lished, the speciﬁc ethnic minority groups who are less
likely to receive the vaccination have not been identi-
ﬁed. Uptake of the vaccination has only been reported
by broad ethnic categories, for example, ‘white’, ‘black’,
‘Asian’ or ‘other’. Many studies group participants in this
way, however, such research is limited as minimal detail is
provided as to the speciﬁc ethnicities included within
each broad category. For example, in the UK, ‘Asian’
mainly denotes individuals from Bangladeshi, Indian and
Pakistani backgrounds, but individuals from each of these
groups are not homogenous. We are therefore unable to
identify whether differences in uptake exist within ethnic
minority populations and as a result are unable to target
interventions towards speciﬁc groups.
The purpose of this study was to explore the relation-
ship between school-level uptake of the HPV vaccination
and ethnicity, as well as uptake and other factors related
to ethnicity (eg, religion, language), to understand
which speciﬁc ethnic minority groups are less likely to
receive the HPV vaccination.
METHODS
Note on terminology
Ethnicity has been deﬁned as a ‘multifaceted quality
that refers to the group to which people belong, and/or
are perceived to belong, as a result of certain shared
characteristics’.11 Bhopal11 states that ethnicity is differ-
ent from race, nationality, religion and migrant status,
but can include facets of these factors. Mirroring this,
we use the term ‘ethnicity’ to refer to the construct of
‘ethnic group’ (eg, white British, African, Bangladeshi)
and ‘ethnicity-related factors’ when referring to other
factors relating to ethnicity (eg, religion, language, level
of proﬁciency in English and duration of residence in
the UK).
Data
Aggregated HPV vaccination uptake rates were obtained
for 195 London schools, for school years 2008/2009,
2009/2010 and 2010/2011 for each dose (prior to
September 2014, three doses were administered), via
personal contacts in borough immunisation teams.
Aggregated data were used as complete individual-level
data were not available.
Uptake data were matched with census data (2011)
that were extracted from the Ofﬁce for National
Statistics website, for the lower super output area
(LSOA) for the postcode of each school. The LSOA is a
geographical area, comprising between 400 and 1200
households.12 We obtained data on ethnicity and four
related factors: language spoken, religion, level of proﬁ-
ciency in English (can speak English very well; can speak
English well; cannot speak English well and cannot
speak English) and duration of residence in the UK
(born in the UK; <2 years; 2 years or more but <5 years;
5 years or more but <10 years and 10 years or more).13
These data at the LSOA level were used as a proxy
measure of the ethnic make-up of the school. We used
census data to identify the most prevalent ethnicity, lan-
guage spoken, religion, level of proﬁciency in English
and duration of residence in the UK for each LSOA.
Almost all of the schools’ LSOAs comprised a resident
population where the majority had the same ethnic
characteristics as the majority of the UK population (ie,
most residents were white British, spoke English as their
main language, were Christian and were born in the
UK). To allow us to explore how vaccination uptake
varies by ethnicity and ethnicity-related factors (among
those from minority groups), the most prevalent non-
majority groupi within each ethnicity and ethnicity-
related factor, for each LSOA, was assigned to each
schoolii (eg, where white British was the most prevalent
ethnicity, the second most common ethnicity in that
LSOA was assigned to the school and where English was
iThe majority group refers to the ethnic characteristics of the majority
of UK residents, not the majority of residents in each LSOA (eg, white
British, spoke English as their ﬁrst language, Christian and born in the
UK were always the majority groups).
iiSome groups were never the most prevalent non-majority group for
any LSOA and so could not be included in the analysis (eg, ‘Buddhist’
was never the most prevalent non-Christian religion and the group
‘cannot speak English’ was never the most prevalent level of
proﬁciency in English for non-native English speakers).
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the most commonly spoken language in that LSOA, the
second most commonly spoken language was assigned
to the school). Where it was not possible to determine
the most prevalent non-majority group (eg, where there
were two non-majority groups of equal prevalence in a
given LSOA), the data were recorded as missing.
Statistical analysis
To maximise complete data, we computed one single
uptake rate for each school, for each dose. We used
2010/2011 as the year of interest, but where data were
missing, we replaced this with the rate for 2009/2010
and 2008/2009 if 2009/2010 data were missing.
Data were normally distributed, so one-way analyses of
variance (ANOVAs) were conducted to examine school-
level differences in uptake by area-level ethnicity and the
four ethnicity-related factors for each of the three doses
of the vaccine, for groups with counts >5. We performed
a subanalysis to determine whether the relationship
between ethnicity and uptake varied by whether each
ethnicity represented a high or low proportion of the
total resident population. Schools were grouped by
whether the most prevalent non-white British ethnicity
in their respective LSOA was a low or high proportion of
the total population (using a median split). Those above
the median (16.3%) were grouped as high and those
below, as low. For each ethnicity we used Mann-Whitney
U tests to examine differences in uptake, for all three
doses of the vaccine separately, between schools cate-
gorised as ‘high’ and ‘low’ (excluding groups with
counts <5).
RESULTS
Overall mean uptake of the vaccination across the 195
schools was 73.3% (SD; 16.6) for dose 1, 70.8% (SD;
17.7) for dose 2 and 66.2% (SD; 19.6) for dose
3. Uptake by ethnicity and other ethnicity-related
factors is presented in table 1,iii along with the results
of the ANOVAs. No signiﬁcant differences were found
between ethnicity and uptake, language and uptake,
religion and uptake or proﬁciency in English and
uptake.
Schools in areas where other white was the most preva-
lent non-white British ethnicity had the lowest rate of
uptake for dose 1 (71.4%) and schools in areas where
Caribbean was the most prevalent non-white British eth-
nicity had the lowest rates of uptake for doses 2 (67.7%)
and 3 (60.8%). Overall, schools in areas where black
ethnicities (African; Caribbean) were the most prevalent
non-white British ethnicities had consistently low rates of
uptake for all three doses. In comparison, schools in
areas where some Asian ethnicities (Bangladeshi; Indian;
other Asian) were the most prevalent non-white British
ethnicities had consistently high rates of uptake for all
three doses.iv
Schools in areas where the most commonly spoken
non-English languages were East Asian, had the lowest
rates of uptake for dose 1 (68.7%) and 2 (67.7%) and
those in areas where Arabic was the most commonly
spoken non-English language had the lowest rates for
dose 3 (63.4%).
Schools in areas where Jewish was the most prevalent
non-Christian religion, were found to have the lowest
rates of uptake for all three doses of the vaccine (dose 1;
61.7%, dose 2; 60.8%, dose 3; 59.2%).
Schools in areas where English was spoken well by
non-native English speakers, had the lowest rates of
uptake for doses 1 (72.5%) and 2 (70.7%) and those in
areas where English was spoken very well had the lowest
rates of uptake for dose 3 (66.2%).
Variability in mean rates of uptake was apparent for
ethnicities that would commonly be grouped into more
broad ethnic categories. For example, for dose 1 mean
uptake rates varied between schools in areas where
Indian (77.3%, SD 8.3), Bangladeshi (84.2%, SD 8.9)
and other Asian (78.3%, SD 12.1) were the most preva-
lent non-majority ethnicities, three ethnicities which are
often grouped into a broad ‘Asian’ category. Similarly,
mean uptake rates for dose 2 varied between schools in
areas where the most prevalent non-majority ethnicities
were African (70.4%, SD 21.3) and Caribbean (67.7%,
SD 26.3), two ethnicities which are often grouped into a
broad ‘black’ category.
The subanalyses showed that schools in areas where
the most prevalent non-white ethnicity represented a
low proportion of the total population had consistently
higher uptake than schools in areas where the most
prevalent non-white ethnicity was a high proportion of
the total population. However, differences were not sig-
niﬁcant (see table 2).
DISCUSSION
This study sought to identify whether differences existed
in school-level uptake of the HPV vaccination by ethni-
city or other ethnicity-related factors, in an attempt to
understand which speciﬁc ethnic minority groups are
less likely to receive the HPV vaccination. Comparisons
were made between groups but no signiﬁcant differences
were found between ethnicity and uptake, or between
any ethnicity-related factors and uptake, although descrip-
tive differences were apparent.
There was evidence that uptake was consistently high
among some Asian ethnicities (Bangladeshi; Indian and
other Asian) and consistently low among black ethnici-
ties (African and Caribbean). This supports previous
research using individual-level data which found that
uptake rates of the vaccination were lower for girls from
iiiUptake rates for groups with counts <5 are not described in the
results section, although are tabulated for completeness. ivPakistani was not included due to small group size (<5).
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black backgrounds than for girls from Asian back-
grounds.7 There was also evidence of variability in mean
uptake rates between ethnicities; differences were appar-
ent between schools based in areas where Indian,
Bangladeshi and Other Asian were the most common
non-white British ethnicity and similarly between schools
in areas where African and Caribbean were the most
common non-white British ethnicity. These ethnicities
are often grouped into the broad ethnic categories
‘Asian’ and ‘black’, respectively, resulting in a loss of
detail about the individual ethnicities, which therefore
limits what we know about their differences. These
results demonstrate that there is variability between eth-
nicities when breaking down broad ethnic categories
and suggests that further exploration is required.
Descriptively, the subanalysis showed that schools in
areas where the most prevalent non-white ethnicity was a
low proportion of the total population had higher
uptake. The reason for conducting this subanalysis was
to explore whether parents’ vaccination choices are
affected by the ethnic make-up of where they live (ie,
ethnic minority parents living in areas where the major-
ity of residents are white British may have higher uptake
of the vaccination). Descriptively, this does appear to be
the case; however, these differences were not signiﬁcant
and require further exploration with a larger sample in
order to be able to draw such conclusions.
Knowledge and acceptance of the HPV vaccination
has been shown to be lower in non-white groups,14
which may help to explain lower uptake rates. Religious
beliefs and fear that the vaccination may encourage prom-
iscuity have been cited as perceived barriers for parents
from ethnic minority backgrounds.10 Furthermore, con-
cerns about the age of vaccination and a lack of perceived
Table 1 Most prevalent non-majority ethnicity and ethnicity-related factors for each school and human papillomavirus (HPV)
vaccination uptake
Mean uptake
N (%)*
Dose 1%
(SD) p Value
Dose 2%
(SD) p Value
Dose 3%
(SD) p Value
Most prevalent non-white British ethnicity 0.172 0.195 0.274
Other white 115 (59.0) 71.4 (17.6) 69.3 (17.9) 64.8 (19.9)
African 25 (12.8) 72.7 (19.7) 70.4 (21.3) 65.6 (24.8)
Indian 20 (10.3) 77.3 (8.3) 75.4 (8.8) 72.1 (11.3)
Bangladeshi 10 (5.1) 84.2 (8.9) 83.0 (10.1) 76.8 (9.1)
Caribbean 12 (6.2) 72.5 (16.7) 67.7 (26.3) 60.8 (25.4)
Other Asian 9 (4.6) 78.3 (12.1) 73.2 (9.4) 69.3 (11.7)
Pakistani† 3 (1.5) 69.5 (10.4) 67.6 (11.3) 63.8 (14.6)
Arab† 1 (0.5) 88.3 78.3 73.3
Most prevalent non-English language‡ 0.235 0.258 0.809
Other European 97 (50.5) 71.6 (17.5) 68.9 (19.1) 65.3 (19.9)
South Asian 68 (35.4) 77.2 (13.3) 75.0 (14.3) 68.8 (18.9)
East Asian 9 (4.7) 68.7 (13.3) 67.7 (12.4) 63.6 (10.7)
Arabic 6 (3.1) 74.6 (12.4) 69.0 (10.4) 63.4 (13.7)
Turkish 6 (3.1) 74.0 (31.8) 72.8 (31.5) 67.1 (34.4)
African† 3 (1.6) 63.2 (26.4) 62.7 (25.8) 56.2 (34.3)
West/Central Asian† 2 (1.0) 54.9 (31.7) 52.9 (30.7) 52.9 (30.7)
French† 1 (0.5) 75.0 75.0 75.0
Most prevalent non-Christian religion 0.099 0.204 0.531
No religion 140 (71.8) 74.0 (15.4) 71.6 (17.0) 66.9 (18.5)
Muslim 43 (22.1) 73.1 (18.3) 70.2 (18.9) 66.0 (21.7)
Jewish 9 (4.6) 61.7 (24.6) 60.8 (24.4) 59.2 (27.4)
Hindu† 2 (1.0) 71.3 (6.5) 68.7 (2.8) 54.2 (16.0)
Sikh† 1 (0.5) 83.3 81.7 78.3
Most prevalent level of proficiency in
English for non-native English speakers‡
0.587 0.877 0.804
Can speak English very well 140 (72.5) 73.9 (15.7) 71.2 (17.0) 66.2 (18.7)
Can speak English well 53 (27.5) 72.5 (18.4) 70.7 (19.2) 67.0 (21.9)
Most prevalent length of residence in the
UK for non-UK born residents (years)†
<2 2 (1.0) 86.7 (3.1) 75.9 (7.9) 74.1 (10.3)
>5<10 1 (0.5) 55.6 55.6 37.0
≥10 192 (98.5) 73.2 (16.6) 70.8 (17.7) 66.3 (19.6)
*Number of schools providing data for at least one dose.
†Variables not included in the analysis of variance (ANOVA) due to small group sizes (<5).
‡N≠195 due to missing data.
4 Rockliffe L, et al. BMJ Open 2017;7:e014527. doi:10.1136/bmjopen-2016-014527
Open Access
risk regarding their daughter’s susceptibility to infection
have also been reported.15 Concerns and beliefs such as
these provide some insight as to why vaccine acceptability
and uptake are lower in ethnic minority groups, although
further research will be required to identify variation
between ethnicities that fall within the same broad ethnic
categories.
The main limitation of this study is the use of ethnicity
data collected at a LSOA level, rather than at an individ-
ual level. While proximity of residence to a school is
usually a criterion for school entry in the UK, the data
may not accurately reﬂect the characteristics of pupils in
some schools. In addition, age-adjusted ethnicity was not
available, so the ethnicity categories assigned to schools
may not represent the school-aged resident population.
There was some clustering of the schools within LSOAs
and this was not taken into account when reporting
mean uptake. No signiﬁcant effects were detected in the
analyses, which may be attributable to the area-level
measure of ethnicity (and related factors), and/or a
small sample size. Owing to this, power was only 0.47 for
the effect size reported for the relationship between
ethnicity and uptake. Based on our calculations, a
sample of 372 schools would have been required to
achieve sufﬁcient power of 0.80.
The main strength of this study is the demonstration
of variability between ethnicities that would normally be
grouped into broad ethnic categories and the provision
of further information about the speciﬁc ethnicities
within the study that have lower uptake of the vaccin-
ation. These ﬁndings add detail to previous research in
this area, although no conclusions can be drawn based
on these results. What this study suggests to us however,
is that policy recommendations should encourage the
complete collection of ethnicity data at an individual
level. This would provide us with a far more accurate
indication about ethnicity and uptake rates and would
not require the use of proxy measures, as used in the
current study. Even where ethnicity is currently recorded
at an individual level, it is incomplete.16 The complete
collection of such data on a national level would allow
us to develop a more thorough understanding of ethnic
inequalities in uptake.
Going forward, further exploration is recommended
with a larger sample size, using individual-level ethnicity
and uptake data. Future research would beneﬁt from
focusing on speciﬁc ethnicities, rather than using broad
ethnic categories to deﬁne participants. As this study has
demonstrated, there is variability in mean uptake rates
within broad ethnic groups. It is important to explore
these differences so that we can gain a better understand-
ing of the perceived barriers to vaccination that may exist
for these speciﬁc groups rather than assuming all ethnici-
ties grouped in any given broad ethnic category make the
same decisions regarding HPV vaccination.
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Table 2 Human papillomavirus (HPV) vaccination uptake for schools where the most prevalent non-white British ethnicity
was a low or high proportion of the total population
Mean uptake
N (%)* Dose 1% (SD) p Value Dose 2% (SD) p Value Dose 3% (SD) p Value
African high 10 (5.1) 70.7 (21.8) 0.688 69.3 (21.3) 0.688 63.0 (25.6) 1.000
African low 15 (7.7) 74.0 (18.9) 71.2 (22.0) 67.2 (25.1)
Indian high 5 (2.6) 81.6 (8.8) 0.303 80.7 (8.5) 0.303 74.2 (18.1) 0.303
Indian low 15 (7.7) 76.0 (8.0) 74.0 (8.4) 71.4 (8.7)
Other white high 66 (33.8) 70.1 (20.5) 0.404 67.4 (21.0) 0.404 64.5 (20.9) 0.647
Other white low 49 (25.1) 73.1 (13.0) 72.0 (12.9) 65.3 (18.7)
Caribbean high 2 (1.0) 61.7 (16.6) † 61.2 (15.9) † 50.9 (24.8) †
Caribbean low 10 (5.1) 74.7 (16.8) 69.0 (28.3) 62.8 (26.4)
Other Asian high 2 (1.0) 69.8 (17.2) † 68.7 (17.6) † 66.0 (20.3) †
Other Asian low 7 (3.6) 80.7 (10.7) 74.7 (7.1) 70.3 (10.1)
Pakistani high 2 (1.0) 74.3 (9.0) † 71.5 (12.9) † 67.6 (18.3) †
Pakistani low 1 (0.5) 60.0 60.0 56.0
Bangladeshi high 10 (5.1) 84.2 (8.9) † 83.0 (10.1) † 76.8 (9.1) †
Bangladeshi low 0 – – –
Arab high 0 – † – † – †
Arab low 1 (0.5) 88.3 78.3 73.3
*Number of schools providing data for at least one dose.
†Group sizes too small for test of difference to be run.
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